Your browser doesn't support javascript.
loading
Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects.
Brown, James; Li, Zhe; Wang, Xi; Kim, Yu Jeong; Wang, Yu-Chen; Zuo, Yanning; Hong, Weizhe; Wang, Pin; Li, Bo; Yang, Lili.
Affiliation
  • Brown J; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, United States.
  • Li Z; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, United States.
  • Wang X; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, United States.
  • Kim YJ; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, United States.
  • Wang YC; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, United States.
  • Zuo Y; Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Hong W; Department of Neurobiology, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Wang P; Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Li B; Department of Neurobiology, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Yang L; Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.
Front Pharmacol ; 13: 970324, 2022.
Article in En | MEDLINE | ID: mdl-36120311

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Country of publication: